[The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
In 18 patients with clinically confirmed arteriosclerosis, angina pectoris attacks and myocardial infarction, a distinct recession of catecholamines (adrenalin and noradrenalin were determined separately) was found in urine, also, a normalization of blood fat parameters. Frequency and intensity of angina pectoris attacks regressed. It is discussed that these effects might be explained by the special composition of VisanoCor.
D000787:Angina Pectoris / Q000188:drug therapy* / Q000652:urine; D003327:Coronary Disease / Q000188:drug therapy; D004155:Diphenhydramine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004837:Epinephrine / Q000652:urine; D006801:Humans; D008620:Meprobamate / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009638:Norepinephrine / Q000652:urine; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; C017250:diphenhydramine, meprobamate, nicotinic acid, pentaerythritol tetranitrate, drug combination; D010417:Pentaerythritol Tetranitrate; D004155:Diphenhydramine; D008620:Meprobamate; D009638:Norepinephrine; D004837:Epinephrine
Studie mit dem Kombinationspräparat VisanoCor bei Patienten mit Angina pectoris unter besonderer Uberwachung der Katecholamine im Harn.